1.Distribution and drug sensitivity test of bacteria of patients on chronic rhinosinusitis with or without nasal polyps.
Jun LI ; Yanqiao WU ; Xiaoming LI ; Bin DI ; Limei WANG
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2016;30(2):115-118
OBJECTIVE:
To study the distribution and drug sensitivity test of bacteria of patients on chronic rhinosinusitis with or without nasal polyps.
METHOD:
The purulent discharges were collected from sinus of 175 patients with chronic rhinosinusitis with or without nasal polyps during endoscopic sinus surgery. The results of germiculture and drug sensitivity test were analyzed.
RESULT:
From 175 specimens, 118 (67%) showed positive results in germiculture. Among them, 79 strains of gram positive bacteria and 39 strains of gram negative bacteria were detected. Staphylococcus epidermidis, Staphylococcus aureus and Staphylococcus haemolyticus were the most common pathogens in gram positive bacteria. The most common pathogens of gram negative bacteria were P. Aeruginosa, Enterobacter aerogenes, Enterobacter cloacae. The sensitive antibiotic on gram positive bacteria were amikacin, Daptomycin, Linezolid, vancomycin, teicoplanin, amoxicillin and clavulanate potassium, cefuroxime, respectively. The sensitive antibiotics on Gram negative bacteria were amikacin, Cefoperazone/sulbactam and imipenem, ceftazidime ceftazidime, aztreonam, levofloxacin, respectively.
CONCLUSION
Bacterial infection was common happened in the sinus cavity of patients with chronic rhinosinusitis with or without nasal polyps. Gram positive bacteria were the main pathogenic bacteria and gram positive bacteria and gram negative bacteria have great differences in the sensitivity of antibiotics. For patients with chronic rhinosinusitis, the using of antibiotics should depend on the drug sensitivity test.
Bacterial Infections
;
complications
;
drug therapy
;
Gram-Negative Bacteria
;
drug effects
;
Gram-Positive Bacteria
;
drug effects
;
Humans
;
Microbial Sensitivity Tests
;
Nasal Polyps
;
microbiology
;
Rhinitis
;
microbiology
;
Sinusitis
;
microbiology
2.Clinical features and risk factors for infections in adult acute leukemia after chemotherapy.
Yiming LUO ; Tingbo LIU ; Siting XIE ; Sili WANG ; Zhihong FANG ; Rui SU ; Zhifeng LI ; Yun HUANG ; Zhijuan LIN ; Mingzhe HAN
Chinese Journal of Hematology 2015;36(12):1020-1024
OBJECTIVETo observe the clinical characteristics of infections in adult acute leukemia (AL)patients during chemotherapy in hospital, and identify the risk factors for infections.
METHODSA retrospective study of patients with AL who underwent chemotherapy between July 2010 and Dec 2014 in the First Affiliated Hospital of Xiamen University was conducted. Clinical features and risk factors for infections were analyzed.
RESULTS191 patients with AL received a total of 728 courses of chemotherapies. During these admissions, 385(52.9%) infections episodes occurred. The common infections sites were lower respiratory tract infection(36.3%,153/374), bloodstream infection(17.1%, 64/374), oral infection(13.6%,51/374), and perianal infection(13.4%, 50/374). 164 strains of pathogenic bacteria were detected. Gram- negative bacteria were recorded in 59.1% of documented pathogens, and Gram- positive bacteria were responsible for 32.9% of infections. Multivariate unconditioned logistic analysis of factors identified consistent independent risk factors for no completely remission(OR=0.142, P< 0.001), duration of neutropenia longer than 7 days(OR=12.764, P<0.001), general wards(OR=1.821, P< 0.001), and hospitalization interval longer than 10 days(OR=0.720, P=0.039).
CONCLUSIONInfections after chemotherapy for AL continues to be common. AL patients with induction chemotherapy or severe neutropenia faced an increased risk of infections by multivariate analysis. And patients with short-term stay or laminar flow wards seem to be less susceptible to infections.
Acute Disease ; Bacterial Infections ; complications ; Gram-Negative Bacteria ; Gram-Positive Bacteria ; Hospitals ; Humans ; Leukemia ; complications ; drug therapy ; microbiology ; Multivariate Analysis ; Neutropenia ; complications ; Remission Induction ; Retrospective Studies ; Risk Factors
3.Spontaneous Bacterial Peritonitis with Sepsis Caused by Enterococcus hirae.
Jong Seop SIM ; Hyoung Su KIM ; Ki Jong OH ; Myung Soo PARK ; Eun Ju JUNG ; Youn Joo JUNG ; Dae Gil KANG ; Seung In SEO ; Won Jin KIM ; Myoung Kuk JANG
Journal of Korean Medical Science 2012;27(12):1598-1600
Selective intestinal decontamination (SID) with norfloxacin has been widely used for the prophylaxis of spontaneous bacterial peritonitis (SBP) because of a high recurrence rate and preventive effect of SID for SBP. However, it does select resistant gut flora and may lead to SBP caused by unusual pathogens such as quinolone-resistant gram-negative bacilli or gram-positive cocci. Enterococcus hirae is known to cause infections mainly in animals, but is rarely encountered in humans. We report the first case of SBP by E. hirae in a cirrhotic patient who have previously received an oral administration of norfloxacin against SBP caused by Klebsiella pneumoniae and presented in septic shock.
Administration, Oral
;
Ampicillin/therapeutic use
;
Anti-Bacterial Agents/therapeutic use
;
Ascitic Fluid/microbiology
;
Enterococcus/*isolation & purification
;
Gram-Positive Bacterial Infections/complications/drug therapy/*microbiology
;
Humans
;
Male
;
Microbial Sensitivity Tests
;
Middle Aged
;
Peritonitis/*diagnosis/drug therapy/microbiology
;
Sepsis/*etiology
4.Clinical analysis of early postoperative pulmonary infection in children after living donor liver transplantation.
Huan-li HAN ; Ying HUANG ; Ming-man ZHANG ; Chun-bao GUO ; Cong-lun PU
Chinese Journal of Pediatrics 2012;50(8):612-616
OBJECTIVETo analyze the condition of early (≤ 30 d) postoperative pulmonary infection in children after living donor liver transplantation (LDLT).
METHODThe clinical data of 36 cases undergoing LDLT in Children's Hospital of Chongqing Medical University were analyzed retrospectively from June 2006 to December 2009.
RESULTOf 36 cases without preoperative respiratory disease, 17 were boys, 19 were girls. Their age ranged from 2 months to 14 years. Pulmonary infection developed in 24 patients, of whom 4 cases died (17%) and 3 deaths were related to pulmonary infection. Pulmonary infection occurred in 17 of 20 infants (85%) and 10 of 11 cases (91%) with liver function of Child-Pugh grade C. Twenty cases (83%) developed pulmonary infection within first 2 weeks after LDLT. Totally 65 pathogenic strains of microorganisms were isolated, in which Gram-negative bacteria, Gram-positive bacteria and fungi were 46 strains, 5 strains, 14 strains respectively. The most frequently isolated bacteria were Pseudomonas aeruginosa (14 strains), Klebsiella pneumoniae (8 strains) and Acinetobacter baumannii (8 strains). Pseudomonas aeruginosa showed a resistance rate of almost 100% to cotrimoxazole, tetracycline, chloramphenicol, ampicillin, the first, the second and some of the third generation cephalosporins. Klebsiella pneumoniae producing extended spectrum beta-lactamase had a resistance rate of almost 100% to beta-lactams except carbapenems. Acinetobacter baumannii was exquisitely susceptible to carbapenems, but showed a high resistance to penicillins and cephalosporins. Candida albicans, which was the most common fungus, showed a susceptibility rate of 100% to amphotericin B. In the LDLT recipients of pulmonary infection, cytomegalovirus (CMV) infections occurred in 2 patients and Epstein Barr virus (EBV) infection in 1 patient.
CONCLUSIONThe incidence of early postoperative pulmonary infection was high in children undergoing LDLT, especially in infants. And the mortality should not be ignored. The high risk period for infection was within the first 2 weeks after operation. The pathogens were mainly Gram-negative bacteria, which showed high and multidrug resistance.
Adolescent ; Anti-Bacterial Agents ; therapeutic use ; Antifungal Agents ; therapeutic use ; Bacterial Infections ; drug therapy ; etiology ; microbiology ; Child ; Child, Preschool ; Drug Resistance, Bacterial ; Female ; Gram-Negative Bacteria ; drug effects ; isolation & purification ; Gram-Positive Bacteria ; drug effects ; isolation & purification ; Humans ; Infant ; Liver Transplantation ; Living Donors ; Lung Diseases ; drug therapy ; etiology ; microbiology ; Male ; Postoperative Complications ; drug therapy ; epidemiology ; etiology ; Retrospective Studies ; Risk Factors
5.A Case of Necrotizing Fasciitis Due to Streptococcus agalactiae, Arcanobacterium haemolyticum, and Finegoldia magna in a Dog-bitten Patient with Diabetes.
Sungsil LEE ; Kyoung Ho ROH ; Chang Ki KIM ; Dongeun YONG ; Jun Yong CHOI ; Jin Woo LEE ; Kyungwon LEE ; Yunsop CHONG
The Korean Journal of Laboratory Medicine 2008;28(3):191-195
We report a case of necrotizing fasciitis involving Streptococcus agalactiae, Arcanobacterium haemolyticum, and Finegoldia magna in a 36-yr-old female diabetic patient, which started after a minor dog bite to the toe of the patient. This case suggested that a trivial infection after a minor dog bite in an immunocompromised patient such as diabetes patient could result in a significant complication such as necrotizing fasciitis. The life-threatening infection was cured by timely above-the-knee amputation, as well as penicillin G and clindamycin therapy.
Actinomycetales Infections/diagnosis/microbiology
;
Adult
;
Animals
;
Anti-Bacterial Agents/therapeutic use
;
Arcanobacterium
;
Bites and Stings/*complications
;
Clindamycin/therapeutic use
;
Diabetes Mellitus/diagnosis/therapy
;
*Dogs
;
Fasciitis, Necrotizing/diagnosis/drug therapy/*microbiology
;
Female
;
Gram-Positive Bacterial Infections/diagnosis/microbiology
;
Humans
;
Penicillin G/therapeutic use
;
Peptostreptococcus
;
Streptococcal Infections/diagnosis/microbiology
;
Streptococcus agalactiae
6.Analysis of antibiotics treatment in 86 cases of liver transplant recipients.
Zhen-guo LIU ; Huan-yu GONG ; Jian-dang ZHOU ; Hao-ye ZHANG
Chinese Journal of Hepatology 2009;17(11):852-855
OBJECTIVETo analyze the characteristic of bacterial infections, and the relationship between antibiotics treatment and bacterial infections after liver transplantation, and to prevent antibiotic-resistant bacterial infections.
METHODS86 liver transplant recipients were retrospected. Different indexes including limited daily dose, the frequency of medication, drug use index were used to evaluate the rationality of the use of antibiotics, three-dimensional test was used to explore extended-spectrum beta-lactamase and AmpC enzyme of Gram-negative bacteria.
RESULTSThe major pathogens of infection after liver transplantation were Enterococcus faecalis, Enterobacter cloacae, fungi and E. coli. Pre-operative antibiotic utilization rate was 83.7%, it was mainly a single use of antibiotics; After- operative antibiotic usage was 100.0%, it was mainly joint use of two or three antibiotics; The top 3 antibiotics used were cephalosporins, the combined enzyme inhibitors and penicillin. Antibiotics with drug utilization index (DUI) more than 1.1 included ampicillin and Lalin proxy. 43.3% and 31.8% of Gram -Negative bacteria produced ESBLs and AmpC, respectively, while 21.3% Gram -Negative bacteria produced two enzymes.
CONCLUSIONThere is high incidence of bacterial infections after liver transplantation. The use of antibiotics is high dose, high-frequency and reasonable; High resistance of bacterial infections was prone to develop and the prevention of the high resistance of bacterial infections is very important.
Adolescent ; Adult ; Aged ; Anti-Bacterial Agents ; administration & dosage ; therapeutic use ; Bacterial Infections ; drug therapy ; etiology ; microbiology ; Child ; Child, Preschool ; Drug Resistance, Bacterial ; Female ; Gram-Negative Bacteria ; drug effects ; enzymology ; isolation & purification ; Gram-Positive Bacteria ; drug effects ; enzymology ; isolation & purification ; Humans ; Infant ; Liver Transplantation ; adverse effects ; methods ; Male ; Microbial Sensitivity Tests ; Middle Aged ; Postoperative Complications ; drug therapy ; epidemiology ; microbiology ; Retrospective Studies ; Young Adult ; beta-Lactamases ; biosynthesis
7.Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma during Treatment with Bortezomib-based Regimens.
Shin Young HYUN ; Sang Hoon HAN ; Soo Jeong KIM ; Ji Eun JANG ; Yundeok KIM ; Hyunsoo CHO ; Jung Yeon LEE ; June Won CHEONG ; Yoo Hong MIN ; Jae Woo SONG ; Jin Seok KIM
Journal of Korean Medical Science 2016;31(4):510-518
The aim of this study was to identify the risk factors associated with severe bacterial infection (SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens. A total of 98 patients with MM were evaluated during 427 treatment courses. SBI occurred in 57.1% (56/98) of the patients and during 19.0% (81/427) of the treatment courses. In the multivariate analysis for the factors associated with the development of SBI in each treatment course, poor performance status (Eastern Cooperative Oncology Group ≥ 2, P < 0.001), early course of therapy (≤ 2 courses, P < 0.001), and pretreatment lymphopenia (absolute lymphocyte count < 1.0 × 10(9)/L, P = 0.043) were confirmed as independent risk factors. The probability of developing SBI were 5.1%, 14.9%, 23.9% and 59.5% in courses with 0, 1, 2, and 3 risk factors, respectively (P < 0.001). In conclusion, we identified three pretreatment risk factors associated with SBI in each course of bortezomib treatment. Therefore, MM patients with these risk factors should be more closely monitored for the development of SBI during bortezomib-based treatment.
Adult
;
Aged
;
Aged, 80 and over
;
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
;
Bacterial Infections/*complications/microbiology
;
Bortezomib/*administration & dosage
;
Female
;
Gram-Negative Bacteria/isolation & purification
;
Gram-Positive Bacteria/isolation & purification
;
Humans
;
Lymphocyte Count
;
Lymphopenia/*therapy
;
Male
;
Middle Aged
;
Multiple Myeloma/complications/*drug therapy/mortality
;
Multivariate Analysis
;
Proportional Hazards Models
;
Retrospective Studies
;
Risk Factors
;
Stem Cell Transplantation
;
Survival Rate
;
Transplantation, Homologous
8.Weissella confusa Bacteremia in an Immune-Competent Patient with Underlying Intramural Hematomas of the Aorta.
Wonmok LEE ; Sun Mi CHO ; Myungsook KIM ; Young Guk KO ; Dongeun YONG ; Kyungwon LEE
Annals of Laboratory Medicine 2013;33(6):459-462
No abstract available.
Anti-Bacterial Agents/therapeutic use
;
Aorta/pathology
;
Bacteremia/*complications/drug therapy/*microbiology
;
Ceftriaxone/therapeutic use
;
Female
;
Gram-Positive Bacterial Infections/*complications/drug therapy/*pathology
;
Hematoma/*complications
;
Humans
;
*Immunocompromised Host
;
Middle Aged
;
Phylogeny
;
RNA, Ribosomal, 16S/analysis
;
Sequence Analysis, DNA
;
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
;
Tomography, X-Ray Computed
;
Weissella/classification/genetics/isolation & purification/*physiology
9.Liver Abscess and Empyema due to Lactococcus lactis cremoris.
Hye Sook KIM ; Dae Won PARK ; Young Kyoung YOUN ; Yu Mi JO ; Jeong Yeon KIM ; Joon Young SONG ; Jang Wook SOHN ; Hee Jin CHEONG ; Woo Joo KIM ; Min Ja KIM ; Won Suk CHOI
Journal of Korean Medical Science 2010;25(11):1669-1671
Lactococcus lactis cremoris infections are very rare in humans. We experienced liver abscess and empyema due to L. lactis cremoris in an immunocompetent adult. A 42-yr-old man was admitted with fever and abdominal pain. Abdominal computed tomography (CT) revealed a liver abscess and chest CT showed loculated pleural effusion consistent with empyema. L. lactis cremoris was isolated from culture of the abscess material and blood. The patient was treated with pus drainage from liver abscess, video-assisted thoracoscopic decortications for empyema, and antibiotics including cefotaxime and levofloxacin. The patient was completely recovered with the treatment. To our knowledge, this is the first report of a L. lactis cremoris infection in Korea.
Adult
;
Anti-Bacterial Agents/therapeutic use
;
Cefotaxime/therapeutic use
;
Drainage
;
Empyema/*diagnosis/*microbiology/surgery
;
Gram-Positive Bacterial Infections/complications/*diagnosis/drug therapy
;
Humans
;
*Lactococcus lactis/drug effects/isolation & purification
;
Liver Abscess/*diagnosis/*microbiology
;
Male
;
Microbial Sensitivity Tests
;
Ofloxacin/therapeutic use
;
Thoracic Surgery, Video-Assisted
;
Tomography, X-Ray Computed